Plain-English translation of NCT07628634 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
This is an early-stage pilot study looking at whether a methionine-reduced diet might help people with solid tumors (cancers that form in organs or tissues like the lungs, skin, bones, or brain). Methionine is a natural building block found in foods like meat, eggs, and dairy. Researchers want to see if eating less of it might benefit people who are already receiving their standard cancer treatment. About 25 people will participate in this study.
Some research suggests that certain types of cancer cells may depend on methionine to survive and grow, so reducing dietary methionine might be a way to support standard cancer treatment. This study will help researchers understand whether this dietary approach is practical and safe for cancer patients.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, you will follow a special methionine-reduced diet (avoiding or limiting foods high in methionine like certain meats, eggs, and dairy) while continuing to receive your standard cancer treatment as planned. The study will track changes in your blood levels and how well you tolerate the diet. Your participation will last as long as you are receiving cancer treatment, and researchers will monitor your health throughout.
AI-generated summary from trial data ยท Jun 12, 2026 ยท Not medical advice
United States